PFKFB3: A Potential Key to Ocular Angiogenesis

Endpoints NewsBiogen's anti-tau Alzheimer's drug misses Phase 2 goal, but claims signs of efficacy

FierceBiotechAptose, facing cash crunch, exits blood cancer pact after Hanmi buyout blocks development

FierceBiotechRegenxbio reaps pivotal win for Duchenne muscular dystrophy gene therapy

CellTransplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson’s disease models

Endpoints NewsRegenxbio hits Duchenne gene therapy milestone, eyes 2027 FDA approval

Endpoints NewsBeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta

Thermo FisherBetween Mettler-Toledo International and Thermo Fisher Scientific, Which Stock Looks Set to Break Out? - Trefis

AgilentAgilent Technologies (A) Valuation Check As New Biopharma Collaborations And Logic Analyzers Expand Growth Story - simplywall.st

PfizerShould you buy pharma stocks? Dr Reddy's, Pfizer - Target prices after Q4 results - Business Today

eLifeEffort produces after-effects costly for others but valued for self

eLifeA meta-analysis suggests that TMS targeting the hippocampal network selectively improves episodic memory

Insilico MedicineSuzhou Ribo Life Science And Insilico Medicine Forge Strategic Alliance To Accelerate AI Powered siRNA Drug Development - BioPharma APAC